Extracellular signal-regulated kinase 1 (Erk1) and Erk2 play crucial roles in cell survival, proliferation, cell adhesion, migration, and differentiation in many tissues. Here we report that the absence of Erk1 and Erk2 in murine hematopoietic cells leads to bone marrow aplasia, leukopenia, anemia and early lethality. Mice doubly-deficient in Erk1 and Erk2 show rapid attrition of hematopoietic stem cells (HSC) and immature progenitors a cell-autonomous manner. Reconstitution studies show that Erk1 and Erk2 play redundant and kinase-dependent functions in hematopoietic progenitor cells. Moreover, in cells transformed by the oncogenic
Introduction
Erk1 and Erk2 (Erk/12) encode serine/threonine kinases belonging to the mitogen-activating protein kinase (MAPK) family, and play critical roles in transmitting signals from a plethora of cytokines and growth factors 1 . ERK1 and ERK2 are >80% identical, and both phosphorylate a myriad of substrates, many of which are cell line-and agonist-specific [1] [2] [3] . Erk1 -/-mice are viable and fertile 4, 5 , whereas Erk2 -/-mice are embryonic lethal due to placental defects [6] [7] [8] [9] .
ERK1/2 activation appears to be required for the survival and differentiation of many types of hematopoietic cells 2, 3, 10 , but most studies of ERK1/2 function in hematopoiesis have employed pharmacological blockade of MEK1 and MEK2, the kinases that activate ERK1/2.
Genetic experiments argued that Erk1 is required for T cell development 4 , although this observation is controversial 5, 9, 11 . T cell-specific deletion of Erk2 also leads to defective T lymphocyte maturation, suggesting that in some cellular contexts, ERK1 cannot compensate for ERK2 9 . By contrast, either Erk1 or Erk2 is sufficient for normal B cell development 12 , although
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From this process is markedly impaired in Erk1/2 doubly-deficient B cells 12 . Together, these observations suggest that ability of Erk1 and Erk2 to compensate for one another might be celltype specific. To date, the role of Erk1/2 in HSC function remains to be characterized. Here we show that Erk1/2 are required in a cell-autonomous manner for the maintenance of HSC.
Methods

Erk1
-/-5 and Erk2 flox/flox9 mice were crossed to Mx1-Cre (The Jackson Laboratory, Bar Harbor, ME) mice, as indicated. All mice were maintained in accord with guidelines approved by the animal welfare committee of University Health Network.
Results and Discussion
To assess ERK1 and ERK2 function in hematopoiesis, we generated -evoked cytokine-independent proliferation. Comparable cell proliferation was observed in cells co-expressing either wild-type Erk1 or Erk2 ( Figure 2E ). By contrast, cells
G12D
-evoked cytokine-independent proliferation. Thus, myeloid cell transformation by oncogenic KRAS requires catalytically active ERK1 or ERK2.
In summary, we found that deletion of both Erk genes results in the rapid loss of HSC and progenitors, leading to leukopenia, anemia, and early lethality in mice. Similar data were reported recently by Staser et al 19 . Together, these results are consistent with previous findings reported by us and others that hematopoietic-specific loss of Ptpn11 (encoding SHP2), a positive regulator of RAS/ERK signaling, also leads to attrition of HSC and progenitors 14, 20 .
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